id CRUZ_8c5e7fd319ba7af509673f601a426060
oai_identifier_str oai:www.arca.fiocruz.br:icict/59232
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Bastos, Thais Sibioni BertiPaula, André Guilherme Portela deLuz, Rebeca Bosso dos SantosGarnique, Anali M. B.Belo, Marco A. A.Eto, Silas FernandesFernandes, Dayanne CarlaFerraris, Fausto KlabundPontes, Leticia Gomes deFrança, Tábata TakahashiBarcellos, Leonardo José GilVeras, Flavio P.Bermejo, PamelaGuidelli, GiovannaManeira, CarlaMello, Fellipe da Silveira Bezerra deTeixeira, GleidsonPereira, Gonçalo Amarante GuimarãesFernandes, Bianca H. VenturaSanches, Paulo R. S.Braz, Helyson Lucas BezerraJorge, Roberta Jeane BezerraMalafaia, GuilhermeCilli, Eduardo M.Olivier, Danilo da SilvaAmaral, Marcos Serrou doMedeiros, Renata J.Condino‑Neto, AntonioCarvalho, Luciani R.Machado‑Santelli, Glaucia M.Charlie‑Silva, IvesGalindo‑Villegas, JorgeBraga, Tárcio Teodoro2023-06-28T19:48:37Z2023-06-28T19:48:37Z2023BASTOS, Thais Sibioni Berti et al. A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity. Scientific Reports, v. 13, n. 8060, p. 1-15, 2023.2045-2322https://www.arca.fiocruz.br/handle/icict/59232porNatureImunidadeZebrafishModels, AnimalPeptidesImmunityPez CebraModelos AnimalesPéptidosInmunidadDanio zébréModèles animauxPeptidesImmunitéSARS-CoV-2COVID-19Peixe-ZebraModelos AnimaisPeptídeosResposta ImuneA novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunityinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal do Paraná. Departamento de Patologia. Curitiba, PR, Brasil.Universidade Federal do Paraná. Departamento de Patologia. Curitiba, PR, Brasil.Universidade Federal do Paraná. Departamento de Patologia. Curitiba, PR, Brasil.Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Biologia Celular. São Paulo, SP, Brasil.Universidade Brasil. Descalvado. São Paulo, SP, Brasil.Instituto Butantan. Centro de Excelência para Descobertas de Alvos Moleculares. Laboratório Especial. São Paulo, SP, Brasil. / Instituto Butantan. Centro de Inovação e Desenvolvimento. Laboratório de Desenvolvimento e Inovação. São Paulo, SP, Brasil.Veterinarian. São Paulo, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Controle da Qualidade em Saúde. Departamento de Farmacologia e Toxicologia, Rio de Janeiro, RJ, Brasil.Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Imunologia. Laboratório de Imunologia Humana. São Paulo, SP, Brasil.Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Imunologia. Laboratório de Imunologia Humana. São Paulo, SP, Brasil.Universidade de Passo Fundo. Programa de Pós-Graduação em Bioexperimentação. Laboratório de Fisiologia de Peixes. Passo Fundo, RS, Brasil. / Universidade Federal de Santa Maria. Programa de Pós-Graduação em Farmacologia . Santa Maria, RS, Brasil.Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Centro de Pesquisa em Doenças Inflamatórias. Ribeirão Preto, SP, Brasil. / Universidade de São Paulo. Escola de Medicina de Ribeirão Preto. Departamento de Farmacologia. Ribeirão Preto, SP, Brasil.Universidade de Campinas. Instituto de Biologia. Laboratório de Genômica e bioEnergia. Campinas, SP, Brasil.Universidade de Campinas. Instituto de Biologia. Laboratório de Genômica e bioEnergia. Campinas, SP, Brasil.Universidade de Campinas. Instituto de Biologia. Laboratório de Genômica e bioEnergia. Campinas, SP, Brasil.Universidade de Campinas. Instituto de Biologia. Laboratório de Genômica e bioEnergia. Campinas, SP, Brasil.Universidade de Campinas. Instituto de Biologia. Laboratório de Genômica e bioEnergia. Campinas, SP, Brasil.Universidade de Campinas. Instituto de Biologia. Laboratório de Genômica e bioEnergia. Campinas, SP, Brasil.Faculdade de Medicina da Universidade de São Paulo. Diretoria Técnica de Apoio ao Ensino e Pesquisa. Laboratório de Controle Genético e Sanitário. São Paulo, SP, Brasil.Universidade Estadual Paulista. Instituto de Química. Araraquara, SP, Brasil.Universidade Federal do Ceará. Faculdade de Medicina. Departamento de Fisiologia e Farmacologia. Fortaleza, CE, Brasil.Universidade Federal do Ceará. Faculdade de Medicina. Departamento de Fisiologia e Farmacologia. Fortaleza, CE, Brasil.Instituto Federal Goiano. Campus Urutaí. Laboratório de Pesquisa Biológica. Urutaí, GO, Brasil.Universidade Estadual Paulista. Instituto de Química. Araraquara, SP, Brasil.Universidade Federal de Tocantins. Centro Integrado de Ciências. Araguaína, TO, Brasil.Universidade Federal de Mato Grosso do Sul. Instituto de Física. Campo Grande, MS, Brasil.Fundação Oswaldo Cruz. Instituto Nacional de Controle da Qualidade em Saúde. Departamento de Farmacologia e Toxicologia. Laboratório de Fisiologia / Zebrafish Facility. Rio de Janeiro, RJ, Brasil.Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Imunologia. Laboratório de Imunologia Humana. São Paulo, SP, Brasil.Faculdade de Medicina da Universidade de São Paulo. Diretoria Técnica de Apoio ao Ensino e Pesquisa. Laboratório de Controle Genético e Sanitário. São Paulo, SP, Brasil.Universidade de São Paulo. Instituto de Ciências Biomédicas. Departamento de Biologia Celular e do Desenvolvimento. Laboratório de Biologia Celular e Molecular. São Paulo, SP, Brasil.Universidade de São Paulo. Departamento de Farmacologia. São Paulo, SP, Brasil.Department of Genomics. Faculty of Biosciences and Aquaculture. Nord University. Bodø, Norway.Universidade Federal do Paraná. Departamento de Patologia. Curitiba, PR, Brasil. / Fundação Oswaldo Cruz. Instituto Carlos Chagas. Programa de Pós-Graduação em Biociências e Biotecnologia. Curitiba, PR, Brasil.Despite all efforts to combat the pandemic of COVID-19, we are still living with high numbers of infected persons, an overburdened health care system, and the lack of an effective and definitive treatment. Understanding the pathophysiology of the disease is crucial for the development of new technologies and therapies for the best clinical management of patients. Since the manipulation of the whole virus requires a structure with an adequate level of biosafety, the development of alternative technologies, such as the synthesis of peptides from viral proteins, is a possible solution to circumvent this problem. In addition, the use and validation of animal models is of extreme importance to screen new drugs and to compress the organism’s response to the disease. Peptides derived from recombinant S protein from SARS-CoV-2 were synthesized and validated by in silico, in vitro and in vivo methodologies. Macrophages and neutrophils were challenged with the peptides and the production of inflammatory mediators and activation profile were evaluated. These peptides were also inoculated into the swim bladder of transgenic zebrafish larvae at 6 days post fertilization (dpf) to mimic the inflammatory process triggered by the virus, which was evaluated by confocal microscopy. In addition, toxicity and oxidative stress assays were also developed. In silico and molecular dynamics assays revealed that the peptides bind to the ACE2 receptor stably and interact with receptors and adhesion molecules, such as MHC and TCR, from humans and zebrafish. Macrophages stimulated with one of the peptides showed increased production of NO, TNF-α and CXCL2. Inoculation of the peptides in zebrafish larvae triggered an inflammatory process marked by macrophage recruitment and increased mortality, as well as histopathological changes, similarly to what is observed in individuals with COVID-19. The use of peptides is a valuable alternative for the study of host immune response in the context of COVID-19. The use of zebrafish as an animal model also proved to be appropriate and effective in evaluating the inflammatory process, comparable to humans.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/59232/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALs41598-023-29588-8OK.pdfs41598-023-29588-8OK.pdfapplication/pdf1953084https://www.arca.fiocruz.br/bitstream/icict/59232/2/s41598-023-29588-8OK.pdf0542a0ae6c9100f6d1a45702c87e85f7MD52s41598-023-39134-Errata.pdfs41598-023-39134-Errata.pdfErrata_Posterior_Publicacaoapplication/pdf815069https://www.arca.fiocruz.br/bitstream/icict/59232/3/s41598-023-39134-Errata.pdfa8717c7a361fafca319fbb13f5039a4cMD53icict/592322023-08-07 11:42:53.202oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-08-07T14:42:53Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
title A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
spellingShingle A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
Bastos, Thais Sibioni Berti
Imunidade
Zebrafish
Models, Animal
Peptides
Immunity
Pez Cebra
Modelos Animales
Péptidos
Inmunidad
Danio zébré
Modèles animaux
Peptides
Immunité
SARS-CoV-2
COVID-19
Peixe-Zebra
Modelos Animais
Peptídeos
Resposta Imune
title_short A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
title_full A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
title_fullStr A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
title_full_unstemmed A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
title_sort A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity
author Bastos, Thais Sibioni Berti
author_facet Bastos, Thais Sibioni Berti
Paula, André Guilherme Portela de
Luz, Rebeca Bosso dos Santos
Garnique, Anali M. B.
Belo, Marco A. A.
Eto, Silas Fernandes
Fernandes, Dayanne Carla
Ferraris, Fausto Klabund
Pontes, Leticia Gomes de
França, Tábata Takahashi
Barcellos, Leonardo José Gil
Veras, Flavio P.
Bermejo, Pamela
Guidelli, Giovanna
Maneira, Carla
Mello, Fellipe da Silveira Bezerra de
Teixeira, Gleidson
Pereira, Gonçalo Amarante Guimarães
Fernandes, Bianca H. Ventura
Sanches, Paulo R. S.
Braz, Helyson Lucas Bezerra
Jorge, Roberta Jeane Bezerra
Malafaia, Guilherme
Cilli, Eduardo M.
Olivier, Danilo da Silva
Amaral, Marcos Serrou do
Medeiros, Renata J.
Condino‑Neto, Antonio
Carvalho, Luciani R.
Machado‑Santelli, Glaucia M.
Charlie‑Silva, Ives
Galindo‑Villegas, Jorge
Braga, Tárcio Teodoro
author_role author
author2 Paula, André Guilherme Portela de
Luz, Rebeca Bosso dos Santos
Garnique, Anali M. B.
Belo, Marco A. A.
Eto, Silas Fernandes
Fernandes, Dayanne Carla
Ferraris, Fausto Klabund
Pontes, Leticia Gomes de
França, Tábata Takahashi
Barcellos, Leonardo José Gil
Veras, Flavio P.
Bermejo, Pamela
Guidelli, Giovanna
Maneira, Carla
Mello, Fellipe da Silveira Bezerra de
Teixeira, Gleidson
Pereira, Gonçalo Amarante Guimarães
Fernandes, Bianca H. Ventura
Sanches, Paulo R. S.
Braz, Helyson Lucas Bezerra
Jorge, Roberta Jeane Bezerra
Malafaia, Guilherme
Cilli, Eduardo M.
Olivier, Danilo da Silva
Amaral, Marcos Serrou do
Medeiros, Renata J.
Condino‑Neto, Antonio
Carvalho, Luciani R.
Machado‑Santelli, Glaucia M.
Charlie‑Silva, Ives
Galindo‑Villegas, Jorge
Braga, Tárcio Teodoro
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Bastos, Thais Sibioni Berti
Paula, André Guilherme Portela de
Luz, Rebeca Bosso dos Santos
Garnique, Anali M. B.
Belo, Marco A. A.
Eto, Silas Fernandes
Fernandes, Dayanne Carla
Ferraris, Fausto Klabund
Pontes, Leticia Gomes de
França, Tábata Takahashi
Barcellos, Leonardo José Gil
Veras, Flavio P.
Bermejo, Pamela
Guidelli, Giovanna
Maneira, Carla
Mello, Fellipe da Silveira Bezerra de
Teixeira, Gleidson
Pereira, Gonçalo Amarante Guimarães
Fernandes, Bianca H. Ventura
Sanches, Paulo R. S.
Braz, Helyson Lucas Bezerra
Jorge, Roberta Jeane Bezerra
Malafaia, Guilherme
Cilli, Eduardo M.
Olivier, Danilo da Silva
Amaral, Marcos Serrou do
Medeiros, Renata J.
Condino‑Neto, Antonio
Carvalho, Luciani R.
Machado‑Santelli, Glaucia M.
Charlie‑Silva, Ives
Galindo‑Villegas, Jorge
Braga, Tárcio Teodoro
dc.subject.other.en_US.fl_str_mv Imunidade
topic Imunidade
Zebrafish
Models, Animal
Peptides
Immunity
Pez Cebra
Modelos Animales
Péptidos
Inmunidad
Danio zébré
Modèles animaux
Peptides
Immunité
SARS-CoV-2
COVID-19
Peixe-Zebra
Modelos Animais
Peptídeos
Resposta Imune
dc.subject.en.en_US.fl_str_mv Zebrafish
Models, Animal
Peptides
Immunity
dc.subject.es.en_US.fl_str_mv Pez Cebra
Modelos Animales
Péptidos
Inmunidad
dc.subject.fr.en_US.fl_str_mv Danio zébré
Modèles animaux
Peptides
Immunité
dc.subject.decs.en_US.fl_str_mv SARS-CoV-2
COVID-19
Peixe-Zebra
Modelos Animais
Peptídeos
Resposta Imune
description Universidade Federal do Paraná. Departamento de Patologia. Curitiba, PR, Brasil.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-06-28T19:48:37Z
dc.date.available.fl_str_mv 2023-06-28T19:48:37Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BASTOS, Thais Sibioni Berti et al. A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity. Scientific Reports, v. 13, n. 8060, p. 1-15, 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/59232
dc.identifier.issn.en_US.fl_str_mv 2045-2322
identifier_str_mv BASTOS, Thais Sibioni Berti et al. A novel insight on SARS‑CoV‑2 S‑derived fragments in the control of the host immunity. Scientific Reports, v. 13, n. 8060, p. 1-15, 2023.
2045-2322
url https://www.arca.fiocruz.br/handle/icict/59232
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Nature
publisher.none.fl_str_mv Nature
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/59232/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/59232/2/s41598-023-29588-8OK.pdf
https://www.arca.fiocruz.br/bitstream/icict/59232/3/s41598-023-39134-Errata.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
0542a0ae6c9100f6d1a45702c87e85f7
a8717c7a361fafca319fbb13f5039a4c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324996826726400